Us central venous catheter market
U.S. Central Venous Catheter Market, by Product Type (Peripherally Inserted Central Catheters (PICC), Implantable Ports, Tunneled Central Venous Catheter, and Non-tunneled Central Venous Catheter), by Design (Single Lumen, Double Lumen, and Multi Lumen), by Composition (Polyurethane, Polyethylene, and Silicon), by Procedure (Cardiovascular Procedure, Chemotherapy Procedure, and Dialysis Procedure), and by End User (Hospitals, Ambulatory Surgical Centers, and Specialty Clinics)- Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031
- Mar 2024
- CMI2610
- 117 Pages
- Excel & Pdf
- Medical Devices
Central venous catheters play a major role in modern healthcare. These catheters allow easy administration of intravenous fluids, blood products, medications, and parenteral nutrition, as well as offer hemodialysis access and hemodynamic monitoring. They are used in various diseases for longer duration therapies such as cancer (chemotherapy) and end stage renal disease (dialysis).
U.S. Central Venous Catheter Market – Impact of Coronavirus (COVID-19) Pandemic
The COVID-19 pandemic and lockdown in various countries across the globe has impacted the financial status of businesses across all sectors. The private healthcare sector is one such sector, which has been majorly impacted by the pandemic. COVID-19 has also affected the economies in three main ways- by directly affecting the production and demand, by creating disruptions in distribution channels, and through its financial impact on companies and financial markets. The increase in central-line–associated bloodstream infections and blood culture contamination rates increase the market growth. For instance, in November 2020, National Center for Biotechnology Information published a report which reported that a there was a significant increase in central-line–associated bloodstream infections and blood culture contamination rates during the pandemic. Blood culture contamination rates were 19% higher during the COVID-19 period, whereas the CLABSI (central-line–associated bloodstream infections) rate during the pandemic increased by 25% in US.
Thus, impact of the Coronavirus (COVID-19) pandemic had driven the growth of the U.S. central venous catheter market during the pandemic.
U.S. central venous catheter market is estimated to be valued at USD 1,142.4 Mn in 2024 and is expected to exhibit a CAGR of 6.2% during the forecast period (2024-2031).
Figure 1. U.S. Central Venous Catheter Market Value (USD Mn), by Product Type, 2024
Increasing number of advantages associated with single lumen is expected to drive the growth of U.S. central venous catheter market
Increasing advantages associated with single lumen drives the growth of U.S. central venous catheter market over the forecast period. For example:
- Single lumen are simplest means of lung isolation
- Does not require any special equipment
- Preferred for emergencies such as contralateral tension pneumothorax
- Lower rate of infection associated with single lumen as compared to double and multiple lumen.
U.S. Central Venous Catheter Market Report Coverage
Report Coverage | Details | ||
---|---|---|---|
Base Year: | 2023 | Market Size in 2024: | US$ 1,142.4 Mn |
Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 To 2031 |
Forecast Period 2024 to 2031 CAGR: | 6.2% | 2031 Value Projection: | US$ 1,738.8 Mn |
Geographies covered: |
|
||
Segments covered: |
|
||
Companies covered: |
AngioDynamics, Inc, C.R. Bard, Inc, Teleflex Incorporated, B. Braun Melsungen AG, Medtronic Plc, Vygon Ltd., Cook Medical, Inc., Argon Medical Devices, Inc.,ICU Medical, Inc.,Theragenics Corporation, Becton, Dickinson and Company,icumedical, Polymedicure, Lepu Medical Technology (Beijing) Co.,Ltd., VOGT MEDICAL, Gilead Sciences, Inc and ZOLL Medical Corporation |
||
Growth Drivers: |
|
||
Restraints & Challenges: |
|
U.S. Central Venous Catheter Market – Restraints
There are various restrains associated with central venous catheter market such as:
- Peripherally inserted central catheters requires experienced specialist, need radiological confirmation, requires training of patients for suitable device care.
- Non-tunneled central line have higher risk of being affected by infection, their usage duration is limited and patients cannot be sent home
- Central line midline catheters cannot be used to draw blood; only solutions which are peripherally compatible cannot be applied.
Figure 2. U.S. Central Venous Catheter Market Share, By Design, 2024
Recent Developments
In November 2023, CorMedix Inc., a biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has approved DefenCath (taurolidine and heparin) catheter lock solution (CLS) to reduce the incidence of catheter-related bloodstream infections (CRBSIs) in a limited population of adult kidney failure patients receiving chronic hemodialysis via a central venous catheter (CVC).
In June 2023, Merit Medical Systems, Inc., a global medical device manufacturer, announced that it has completed the purchase of Bluegrass Vascular Technologies, Inc.'s Surfacer Inside-Out Access Catheter System for a total cash consideration of USD 32.5 million. The Surfacer System is a life-saving device for hemodialysis patients on catheters, as well as patients with other illnesses requiring venous access, who experience central venous occlusions.
In August 2022, Teleflex Incorporated, a leading global provider of medical technologies, announced that it has been granted a contract by Vizient, Inc., the largest member-driven healthcare performance improvement firm in the U.S., to deliver Central Venous Access products. Vizient Inc. offers solutions and services that improve the delivery of high-value care by harmonizing cost, quality, and market performance for more than half of the country's acute care providers.
Increasing use of peripherally inserted central catheters is expected to bolster the U.S. central venous catheter market growth over the forecast period.
Increasing use of peripherally inserted central catheters associated with low complications is expected to drive the growth of U.S. central venous catheter market over the forecast period. For instance, in May 2021, Journal of Medicine and Life, a peer-reviewed open access journal, published a report which stated that PICCs (peripherally inserted central catheters) may be used as a safe option for central venous access in children either in the intermediate- or long-term. New types of PICC may facilitate broader indications and provide longer dwell times. PICC placement can be learned easily, usually requires light sedation and/or local anesthesia, and seldom causes serious perioperative risks. Application of assisted visualization and having well-educated staff could improve the insertion success rate and reduce the complications of PICCs.
U.S. Central Venous Catheter Market - Competitive Landscape
Key players operating in the global osteoporosis drugs market include AngioDynamics, Inc, C.R. Bard, Inc, Teleflex Incorporated, B. Braun Melsungen AG, Medtronic Plc, Vygon Ltd., Cook Medical, Inc., Argon Medical Devices, Inc.,ICU Medical, Inc.,Theragenics Corporation, Becton, Dickinson and Company,icumedical, Polymedicure, Lepu Medical Technology (Beijing) Co.,Ltd., VOGT MEDICAL, Gilead Sciences, Inc and ZOLL Medical Corporation
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Design
- Market Snippet, By Composition
- Market Snippet, By Procedure
- Market Snippet, By End User
- Coherent Opportunity Map (COM)
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- PEST Analysis
- PORTER’s Analysis
- Mergers and Acquisitions
- Regulatory Scenario
- Reimbursement Scenario
- Epidemiology
- Market Dynamics
- U.S. Central Venous Catheter Market- Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- COVID-19 Impact on the market
- U.S. Central Venous Catheter Market, By Product Type, 2019 – 2031, (US$ Million)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 – 2031
- Segment Trends
- Peripherally Inserted Central Catheters (PICC)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Million)
- Implantable Ports
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Million)
- Tunneled Central Venous Catheter
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Million)
- Non-tunneled Central Venous Catheter
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Million)
- Overview
- U.S. Central Venous Catheter Market, By Design, 2019 – 2031, (US$ Million)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 – 2031
- Segment Trends
- Single Lumen
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Million)
- Double Lumen
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Million)
- Multi Lumen
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Million)
- Overview
- U.S. Central Venous Catheter Market, By Composition, 2019 – 2031, (US$ Million)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 – 2031
- Segment Trends
- Polyurethane
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Million)
- Polyethylene
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Million)
- Silicon
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Million)
- Overview
- U.S. Central Venous Catheter Market, By Procedure, 2019 – 2031, (US$ Million)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 – 2031
- Segment Trends
- Cardiovascular Procedure
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Million)
- Chemotherapy Procedure
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Million)
- Dialysis Procedure
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Million )
- Overview
- U.S. Central Venous Catheter Market, By End User, 2019 – 2031, (US$ Million)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 – 2031
- Segment Trends
- Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Million)
- Ambulatory Surgical Centers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Million)
- Specialty Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Million )
- Overview
- Competitive Landscape
- Heat Map Analysis
- Company Profile
- AngioDynamics, Inc
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- R. Bard, Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Teleflex Incorporated
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Braun Melsungen AG
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Medtronic Plc
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Vygon Ltd.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Cook Medical, Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Argon Medical Devices, Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- ICU Medical, Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Theragenics Corporation
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Becton, Dickinson and Company
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Polymedicure
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Lepu Medical Technology (Beijing) Co., Ltd.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- VOGT MEDICAL
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Gilead Sciences, Inc
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- ZOLL Medical Corporation
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- AngioDynamics, Inc
- Analyst Recommendation
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
- Section
- References
- Research Methodology
- About Us and Sales Contact
Detailed Segmentation:
- U.S. Central Venous Catheter Market, By Product Type:
- Peripherally Inserted Central Catheters (PICC)
- Implantable Ports
- Tunneled Central Venous Catheter
- Non-tunneled Central Venous Catheter
- U.S. Central Venous Catheter Market, By Design:
- Single Lumen
- Double Lumen
- Multi Lumen
- U.S. Central Venous Catheter Market, By Composition:
- Polyurethane
- Polyethylene
- Silicon
- U.S. Central Venous Catheter Market, By Procedure:
-
- Cardiovascular Procedure
- Chemotherapy Procedure
- Dialysis Procedure
- U.S. Central Venous Catheter Market, By End User:
- Hospital
- Ambulatory Surgical Centers
- Specialty Clinics